ATYPICAL HELLP SYNDROME OR ATYPICAL HEMOLYTIC UREMIC SYNDROME?
- Authors: KALACHIN K.A1, PYREGOV A.V1, FEDOROVA T.A1, GRISHCHUK K.I1, SHMAKOV R.G1
-
Affiliations:
- Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Issue: No 1 (2017)
- Pages: 94-102
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247859
- ID: 247859
Cite item
Abstract
Full Text
About the authors
K. A KALACHIN
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: Konstantin.Kalachin@yandex.ru
anesthesiologist-resuscitator Moscow 117997, Ac. Oparina str. 4, Russia
A. V PYREGOV
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: pyregov@mail.ru
MD, Head of the Department of Anesthesiology and Resuscitation Moscow 117997, Ac. Oparina str. 4, Russia
T. A FEDOROVA
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: t_fedorova@oparina4.ru
MD, Professor, Head of the Department of Transfusion and extracorporeal blood correction Moscow 117997, Ac. Oparina str. 4, Russia
K. I GRISHCHUK
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: K_grischuk@oparina4.ru
anesthesiologist-resuscitator Moscow 117997, Ac. Oparina str. 4, Russia
R. G SHMAKOV
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: r_shmakov@oparina4.ru
chief physician Moscow 117997, Ac. Oparina str. 4, Russia
References
- Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am. J. Obstet. Gynecol. 1982; 142(2): 159-67.
- Серов В.Н., Сухих Г.Т., Баранов И.И., Пырегов А.В., Тютюнник В.Л., Шмаков Р.Г. Неотложные состояния в акушерстве. Руководство для врачей. М.: ГЭОТАР-Медиа; 2011. 784с.
- Aydin S., Ersan F., Ark C., Arioglu Aydin C. Partial HELLP syndrome: maternal, perinatal, subsequent pregnancy and long-term maternal outcomes. J. Obstet. Gynaecol. Res. 2014; 40(4): 932-40.
- Abildgaard U., Heimdal K. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013; 166(2): 117-23.
- Dusse L.M., Alpoim P.N., Silva J.T., Rios D.R., Brandao A.H., Cabral A.C. Revisiting HELLP syndrome. Clin. Chim. Acta. 2015; 451(Pt B): 117-20.
- Martin J.N. Jr., Rinehart B.K., May W.L., Magann E.F., Terrone D.A., Blake P.G. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am. J. Obstet. Gynecol. 1999; 180(6, Pt 1): 1373-84.
- Виноградова М.А., Федорова Т.А., Чупрынин В.Д., Тютюник В.Л., Кан Н.Е., Вередченко А.В., Хилькевич Е.Г. Рациональная комплексная терапия с проведением симультанных операций при рефрактерной иммунной тромбоцитопении и беременности. Акушерство и гинекология. 2013; 9: 118-22.
- Burrows R.F., Kelton J.G. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N. Engl. J. Med. 1993; 329(20): 1463-6.
- Sainio S., Kekomaki R., Riikonen S., Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstet. Gynecol. Scand. 2000; 79(9): 744-9.
- Rodger M., Sheppard D., Gdndara E., Tinmouth A. Haematological problems in obstetrics. Best Pract. Res. Clin. Obstet. Gynaecol. 2015; 29(5): 671-84.
- Макацария А.Д., Акиньшина С.В., Бицадзе В.О. Преэклампсия и HELLP-синдром как проявление тромботической микроангиопатии. Акушерство и гинекология. 2014; 4: 4-10.
- Martin J.N. Jr., Stedman C. Imitators of preeclampsia and HELLP syndrome. Obstet. Gynecol. Clin. North Am. 1991; 18: 181-98.
- Sibai B. Imitators of severe preeclampsia. Obstet. Gynecol. 2007; 109(4): 956-66.
- Pourrat O., Coudroy R., Pierre F. Differentiation between severe HELLP syndrome and thrombotic microangiopathy, thrombotic thrombocytopenic purpura and other imitators. Eur. J. Obstet. Gynecol. Reprod. Biol. 2015; 189: 68-72.
- Шилов Е.М., ред. Национальные клинические рекомендации по лечению отдельных нефропатий. Сборник клинических рекомендаций. М.: Белый Ветер; 2015. 312с.
- Gaggl M., Aigner C., Sunder-Plassmann G., Schmidt A. Thrombotic microangiopathy: relevant new aspects for intensive care physicians. Med. Klin. Intensivmed. Notfmed. 2016; 111(5): 434-9.
- Thomas M.R., Robinson S., Scully M.A. How we manage thrombotic microangiopathies in pregnancy. Br. J. Haematol. 2016; 173(6): 821-30.
- Fakhouri F. Pregnancy-related thrombotic microangiopathies: clues from complement biology. Transfus. Apher. Sci. 2016; 54(2): 199-202.
- Tsokos M., Longauer F., Kardosova V., Gavel A., Anders S., Schulz F. Maternal death in pregnancy from HELLP syndrome. A report of three medico-legal autopsy cases with special reference to distinctive histopathological alterations. Int. J. Legal Med. 2002; 116(1): 50-3.
- Сидорова И.С., Милованов А.П., Никитина Н.А., Рзаева А.А. Патоморфологические особенности изменений в почках при тяжелой преэклампсии. Российский вестник акушера-гинеколога. 2014; 14(1): 4-9.
- Wijnsma K.L., van Bommel S.A., van der Velden T., Volokhina E., Schreuder M.F., van den Heuvel L.P., van de Kar N.C. Fecal diagnostics in combination with serology: best test to establish STEC-HUS. Pediatr. Nephrol. 2016; 31(11): 2163-70.
- Ake J.A., Jelacic S., Ciol M.A., Watkins S.L., Murray K.F., Christie D.L. et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics. 2005; 115(6): e673-80.
- Leu H., Sugimoto N., Shimizu M., Toma T., Wada T., Ohta K., Yachie A. Tumor necrosis factor-а modifies the effects of Shiga toxin on glial cells. Int. Immunopharmacol. 2016; 38: 139-43.
- Mannucci P.M., Peyvandi Е.В. TTP and ADAMTS13: when is testing appropriate? Hematol. Am. Soc. Hematol. Educ. Program. 2007: 121-6.
- Kentouche K., Voigt A., Schleussner E., Schneppenheim R., Budde U., Beck J.F. et al. Pregnancy in Upshaw-Schulman syndrome. Hamostaseologie. 2013; 33(2): 144-8.
- Pavenski K., Cataland S., Kremer Hovinga J., Thomas M., Vanhoorelbeke K. Thrombotic thrombocytopenic pupura (TTP) dinner symposium proceedings. Expert Rev. Hematol. 2016; 9(8): 733-5.
- Scully M., Hunt B.J., Benjamin S., Liesner R., Rose P., Peyvandi F. et al.; British Committee for Standards in Haematology. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br. J. Haematol. 2012; 158(3): 323-35.
- Rafiq A., Tariq H., Abbas N., Shenoy R. Atypical hemolytic-uremic syndrome: a case report and literature review. Am. J. Case Rep. 2015; 16: 109-14.
- Cataland S.R., Wu H.M. Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies. Eur. J. Intern. Med. 2013; 24(6): 486-91.
- Réti M., Farkas P., Csuka D., Razso K., Schlammadinger Á., Udvardy M.L. et al. Complement activation in thrombotic thrombocytopenic purpura. Thromb. Haemost. 2012; 10(5): 791-8.
- Loirat C., Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J. Rare Dis. 2011; 6: 60.
- Fakhouri F., Hourmant M., Campistol J.M., Cataland S.R., Espinosa M., Gaber A.O. et al. Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial. Am. J. Kidney Dis. 2016; 68(1): 84-93.
- Долгушина В.Ф., Чулков В.С., Вереина Н.К., Синицын С.П. Акушерские осложнения при различных формах артериальной гипертензии у беременных. Акушерство и гинекология. 2013; 10: 33-9.